Share this article
Share this article
DES MOINES, Iowa, April 15, 2021 /PRNewswire/ Kemin Industries, a global ingredient manufacturer that strives to sustainably transform the quality of life every day for 80 percent of the world with its products and services, has announced the publication of a clinical study on Kemin Human Nutrition and Health s DailyZz
™ sleep ingredient. Michael Grandner, Ph.D., an internationally recognized expert on sleep and health and director of the Sleep and Health Research Program at the University of Arizona Health Sciences, led the study.
The study found that DailyZz may improve sleep quality and daytime functioning in healthy individuals with occasional sleep complaints. The 30-day, double-blind, placebo-controlled, randomized study assessed 89 individuals, examining if a polyphenol botanical blend could improve sleep and/or daytime functioning.
Newly Published Clinical Study on Sleep Showcases Benefits of Kemin s DailyZz™ for Next-day Performance and Healthy Quality of Sleep
apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.
Cholesterol might hold key to new therapies for diabetes, Alzheimer s disease
dailyexcelsior.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailyexcelsior.com Daily Mail and Mail on Sunday newspapers.
Society of Interventional Radiology names Matthew S Johnson, M D , FSIR, president for 2021-2022
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.